MET - MetLife, Inc.
NYSE
->
Financial Services
->
Insurance—Life
New York,
United States
Type: Equity
MET price evolution
MET
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $20786 | $19840 | $20639 | |
| Short term investments | ||||
| Net receivables | $31820 | $29986 | $28971 | |
| Inventory | ||||
| Total current assets | ||||
| Long term investments | ||||
| Property, plant & equipment | ||||
| Goodwill & intangible assets | $8950 | $9037 | $9236 | |
| Total noncurrent assets | ||||
| Total investments | $436829 | $440004 | $446137 | |
| Total assets | $704976 | $675745 | $677576 | $687584 |
| Current liabilities | ||||
| Accounts payable | $17719 | $17470 | $17524 | |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $785 | $755 | $494 | $505 |
| Long term debt | $18441 | $17972 | $19134 | $18709 |
| Total noncurrent liabilities | ||||
| Total debt | $18917 | $19851 | $19465 | |
| Total liabilities | $674091 | $648205 | $649041 | $657569 |
| Shareholders' equity | ||||
| Retained earnings | $41765 | $40873 | $40350 | $40146 |
| Other shareholder equity | -$17240 | -$20736 | -$2958 | -$19242 |
| Total shareholder equity | $27252 | $28535 | $30015 | |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $20639 | $20195 | $20047 | $19795 |
| Short term investments | ||||
| Net receivables | $28971 | $17461 | $17149 | $17870 |
| Inventory | ||||
| Total current assets | ||||
| Long term investments | ||||
| Property, plant & equipment | $3561 | $1861 | $2210 | $2614 |
| Goodwill & intangible assets | $9236 | $9297 | $9535 | $10112 |
| Total noncurrent assets | ||||
| Total investments | $446137 | $433293 | $494821 | $508519 |
| Total assets | $687584 | $666611 | $759708 | $795146 |
| Current liabilities | ||||
| Accounts payable | $17524 | $20937 | $31920 | $29475 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $505 | $562 | $3796 | $5548 |
| Long term debt | $18709 | $17805 | $17089 | $15448 |
| Total noncurrent liabilities | ||||
| Total debt | $19465 | $18696 | $18196 | $18994 |
| Total liabilities | $657569 | $639571 | $691959 | $720329 |
| Shareholders' equity | ||||
| Retained earnings | $40146 | $41953 | $41197 | $36491 |
| Other shareholder equity | -$19242 | -$27083 | $10919 | $18072 |
| Total shareholder equity | $30015 | $27040 | $67482 | $74558 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $18440 | $17823 | $16057 | $19028 |
| Cost of revenue | $13441 | $11795 | ||
| Gross Profit | $4382 | $4262 | ||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $16189 | $3180 | $3217 | $17818 |
| Operating income | $1202 | $1045 | ||
| Income from continuing operations | ||||
| EBIT | $1195 | $1037 | ||
| Income tax expense | $653 | $249 | $170 | $327 |
| Interest expense | -$257 | -$269 | ||
| Net income | ||||
| Net income | $1275 | $946 | $867 | $574 |
| Income (for common shares) | $912 | $800 | ||
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $66905 | $69898 | $71080 | $67842 |
| Cost of revenue | $55005 | $50368 | $47765 | |
| Gross Profit | $14893 | $20712 | $20077 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $63698 | $12034 | $12586 | $13150 |
| Operating income | $2859 | $8126 | $6927 | |
| Income from continuing operations | ||||
| EBIT | $2840 | $8105 | $6916 | |
| Income tax expense | $560 | $301 | $1551 | $1509 |
| Interest expense | -$1045 | |||
| Net income | ||||
| Net income | $1380 | $2539 | $6554 | $5407 |
| Income (for common shares) | $2354 | $6353 | $5191 | |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $946 | $867 | $607 | |
| Operating activities | ||||
| Depreciation | $718 | |||
| Business acquisitions & disposals | -$377 | -$32 | -$131 | |
| Stock-based compensation | ||||
| Total cash flows from operations | $3490 | $2328 | $5182 | |
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | -$850 | -$2581 | $725 | |
| Total cash flows from investing | -$6129 | -$1340 | -$2627 | $576 |
| Financing activities | ||||
| Dividends paid | -$1317 | -$389 | -$377 | -$386 |
| Sale and purchase of stock | -$855 | -$1172 | -$859 | |
| Net borrowings | -$1208 | $328 | $186 | |
| Total cash flows from financing | -$2612 | -$1205 | -$261 | -$176 |
| Effect of exchange rate | -$120 | $1 | -$239 | $145 |
| Change in cash and equivalents | $1126 | $946 | -$799 | $5727 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $1578 | $2539 | $6554 | $5407 |
| Operating activities | ||||
| Depreciation | $718 | $673 | $694 | $619 |
| Business acquisitions & disposals | -$914 | $203 | $3180 | -$2851 |
| Stock-based compensation | ||||
| Total cash flows from operations | $13721 | $13204 | $12596 | $11639 |
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | -$9189 | -$2795 | -$14321 | -$15857 |
| Total cash flows from investing | -$10246 | -$2620 | -$11187 | -$18569 |
| Financing activities | ||||
| Dividends paid | -$1566 | -$1598 | -$1647 | -$1657 |
| Sale and purchase of stock | -$3103 | -$3326 | -$4303 | -$1151 |
| Net borrowings | $712 | $878 | -$632 | $877 |
| Total cash flows from financing | -$2940 | -$10108 | -$1375 | $10729 |
| Effect of exchange rate | -$91 | -$397 | -$478 | $163 |
| Change in cash and equivalents | $444 | $79 | -$444 | $3962 |
News
Fundamentals
| Market cap | $49.33B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 693.70M |
| Revenue | $71.35B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $3.66B |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | 13.47 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 0.69 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | $5.28 |
|---|---|
| ROA | 0.53% |
| ROE | N/A |
| Debt/Equity | 21.91 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |